Synthesis and Biological Evaluation of Novel FtsZ-targeted 3-arylalkoxy-2,6-difluorobenzamides as Potential Antimicrobial Agents

被引:10
作者
Qiang, Shengsheng [1 ]
Wang, Changde [1 ]
Venter, Henrietta [2 ]
Li, Xin [1 ]
Wang, Yi [1 ]
Guo, Liwei [1 ]
Ma, Ruixin [3 ]
Ma, Shutao [1 ]
机构
[1] Shandong Univ, Sch Pharmaceut Sci, Key Lab Chem Biol, Dept Med Chem,Minist Educ, 44 West Culture Rd, Jinan 250012, Peoples R China
[2] Univ S Australia, Sansom Inst Hlth Res, Sch Pharm & Med Sci, GPO Box 2471, Adelaide, SA 5001, Australia
[3] Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao 266003, Peoples R China
基金
中国国家自然科学基金;
关键词
2,6-difluorobenzamide; antibacterial activity; FtsZ inhibitors; on-target activity; synthesis; BACTERIAL-CELL-DIVISION; PROTEIN FTSZ; ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS; INHIBITORS; DERIVATIVES;
D O I
10.1111/cbdd.12658
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Novel series of 3-O-arylalkylbenzamide and 3-O-arylalkyl-2,6-difluorobenzamide derivatives were synthesized and evaluated for their on-target activity and antibacterial activity. The results indicated that the 3-O-arylalkyl-2,6-difluorobenzamide derivatives possessed much better on-target activity and antibacterial activity than the 3-O-arylalkylbenzamide derivatives. Among them, 3-O-chlorobenzyl derivative 36 was the most effective in antibacterial activity (0.5, 4, and 8 mu g/mL) against Bacillus subtilis ATCC9372, methicillin-resistant Staphylococcus aureus ATCC29213, and penicillin-resistant Staphylococcus aureus PR, while 3-O-methylbenzyl derivative 41 only exhibited the most potent activity (2 mu g/mL) against Staphylococcus aureus ATCC25923.
引用
收藏
页码:257 / 264
页数:8
相关论文
共 21 条
[21]  
Tarai Bansidhar, 2013, J Lab Physicians, V5, P71, DOI 10.4103/0974-2727.119843